109 related articles for article (PubMed ID: 2500756)
1. Distribution of drugs over whole blood: I. The transport function of whole blood for valproate.
Driessen O; Treuren L; Meijer JW
Ther Drug Monit; 1989; 11(4):384-9. PubMed ID: 2500756
[TBL] [Abstract][Full Text] [Related]
2. Distribution of drugs over whole blood: II. The transport function of whole blood for phenytoin.
Driessen O; Treuren L; Meijer JW; Hermans J
Ther Drug Monit; 1989; 11(4):390-400. PubMed ID: 2741186
[TBL] [Abstract][Full Text] [Related]
3. Distribution of drugs over whole blood: III. The transport function of whole blood for hydrocortisone.
Driessen O; Treuren L; Moolenaar AJ; Meijer JW
Ther Drug Monit; 1989; 11(4):401-7. PubMed ID: 2741187
[TBL] [Abstract][Full Text] [Related]
4. In vivo distribution of hydrocortisone over whole blood: a novel method for the extraction of erythrocytes.
Driessen O; Treuren L; Moolenaar A; Meijer JW; Verheijen P
Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):119-26. PubMed ID: 2319835
[TBL] [Abstract][Full Text] [Related]
5. Disposition and protein binding of valproic acid in the developing rat.
Haberer LJ; Pollack GM
Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869
[TBL] [Abstract][Full Text] [Related]
6. In vivo microdialysis for pharmacokinetic investigations: a plasma protein binding study of valproate in rabbits.
Nakashima M; Takeuchi N; Hamada M; Matsuyama K; Ichikawa M; Goto S
Biol Pharm Bull; 1994 Dec; 17(12):1630-4. PubMed ID: 7735208
[TBL] [Abstract][Full Text] [Related]
7. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent distribution volumes of total and unbound valproate in guinea-pigs: consequence of non-linear plasma protein binding.
Yu HY; Shen YZ
Biopharm Drug Dispos; 1996 Apr; 17(3):237-47. PubMed ID: 8983398
[TBL] [Abstract][Full Text] [Related]
9. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
Yamamura N; Imura K; Naganuma H; Nishimura K
Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
[TBL] [Abstract][Full Text] [Related]
10. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes.
Ogawa K; Yumoto R; Hamada N; Nagai J; Takano M
Epilepsy Res; 2006 Sep; 71(1):76-87. PubMed ID: 16806827
[TBL] [Abstract][Full Text] [Related]
11. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
Urien S; Albengres E; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytes and the transport of drugs and endogenous compounds.
Highley MS; De Bruijn EA
Pharm Res; 1996 Feb; 13(2):186-95. PubMed ID: 8932435
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison.
Hendrickx AG; Nau H; Binkerd P; Rowland JM; Rowland JR; Cukierski MJ; Cukierski MA
Teratology; 1988 Oct; 38(4):329-45. PubMed ID: 3149039
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic study to determine the drug interaction between valproate and propranolol.
Nemire RE; Toledo CA; Ramsay RE
Pharmacotherapy; 1996; 16(6):1059-62. PubMed ID: 8947979
[TBL] [Abstract][Full Text] [Related]
15. In vivo plasma protein binding interaction between valproic acid and naproxen.
Grimaldi R; Lecchini S; Crema F; Perucca E
Eur J Drug Metab Pharmacokinet; 1984; 9(4):359-63. PubMed ID: 6442704
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal elimination in acute valproic acid poisoning.
Thanacoody RH
Clin Toxicol (Phila); 2009 Aug; 47(7):609-16. PubMed ID: 19656009
[TBL] [Abstract][Full Text] [Related]
17. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.
Omoda K; Murakami T; Yumoto R; Nagai J; Maeda Y; Kiribayashi Y; Takano M
J Pharm Sci; 2005 Aug; 94(8):1685-93. PubMed ID: 15986463
[TBL] [Abstract][Full Text] [Related]
18. Investigation of low levels of plasma valproic acid concentration following simultaneous administration of sodium valproate and rizatriptan benzoate.
Hokama N; Hobara N; Kameya H; Ohshiro S; Hobara N; Sakanashi M
J Pharm Pharmacol; 2007 Mar; 59(3):383-6. PubMed ID: 17331341
[TBL] [Abstract][Full Text] [Related]
19. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
Stapleton SL; Thompson PA; Ou CN; Berg SL; McGuffey L; Gibson B; Blaney SM
Cancer Chemother Pharmacol; 2008 Apr; 61(4):647-52. PubMed ID: 17541590
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent pharmacokinetics and metabolism of valproic acid in newborn lambs and adult sheep.
Wong H; Rurak DW; Kumar S; Kwan E; Abbott FS; Riggs KW
Drug Metab Dispos; 2001 May; 29(5):664-75. PubMed ID: 11302932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]